Related references
Note: Only part of the references are listed.IL-37 Attenuates Lung Fibrosis by Inducing Autophagy and Regulating TGF-β1 Production in Mice
Mi So Kim et al.
JOURNAL OF IMMUNOLOGY (2019)
Interleukin-1 Family Cytokines: Keystones in Liver Inflammatory Diseases
Louise Barbier et al.
FRONTIERS IN IMMUNOLOGY (2019)
Interleukin-37 Inhibits Colon Carcinogensis During Chronic Colitis
Steffeni Mountford et al.
FRONTIERS IN IMMUNOLOGY (2019)
Introduction to the interleukin-1 family of cytokines and receptors: Drivers of innate inflammation and acquired immunity
Charles A. Dinarello
IMMUNOLOGICAL REVIEWS (2018)
Ethanol-mediated suppression of IL-37 licenses alcoholic liver disease
Felix Grabherr et al.
LIVER INTERNATIONAL (2018)
Interleukin-37 Attenuates Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice
Yan Li et al.
INFLAMMATION (2018)
Suppression of innate inflammation and immunity by interleukin-37
Charles A. Dinarello et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Beneficial effects of IL-37 after spinal cord injury in mice
Marina Coll-Miro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation
Giulio Cavalli et al.
RHEUMATOLOGY (2016)
IL-37 suppresses hepatocellular carcinoma growth by converting pSmad3 signaling from JNK/pSmad3L/c-Myc oncogenic signaling to pSmad3C/P21 tumor-suppressive signaling
Rui Liu et al.
ONCOTARGET (2016)
Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4-/- mouse model
Florian P. Reiter et al.
WORLD JOURNAL OF HEPATOLOGY (2016)
Hepatic Inflammation and Fibrosis: Functional Links and Key Pathways
Ekihiro Seki et al.
HEPATOLOGY (2015)
Interleukin-1 Family Cytokines in Liver Diseases
Hiroko Tsutsui et al.
MEDIATORS OF INFLAMMATION (2015)
IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction
Claudia A. Nold-Petry et al.
NATURE IMMUNOLOGY (2015)
Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8
Suzhao Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Interleukin 37 Expression Inhibits STAT3 to Suppress the Proliferation and Invasion of Human Cervical Cancer Cells
Sen Wang et al.
JOURNAL OF CANCER (2015)
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Carmen G. Tag et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2015)
Interleukin-37 ameliorates myocardial ischaemia/reperfusion injury in mice
B. Wu et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Macrophage Plasticity and Polarization in Liver Homeostasis and Pathology
Antonio Sica et al.
HEPATOLOGY (2014)
Intestinal Expression of the Anti-Inflammatory Interleukin-1 Homologue IL-37 in Pediatric Inflammatory Bowel Disease
Simon Weidlich et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2014)
Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses
Ana-Maria Bulau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
IL-37 protects against obesity-induced inflammation and insulin resistance
Dov B. Ballak et al.
NATURE COMMUNICATIONS (2014)
Interleukin-37 Mediates the Antitumor Activity in Hepatocellular Carcinoma: Role for CD57+NK Cells
Jing-Jing Zhao et al.
SCIENTIFIC REPORTS (2014)
Interleukins in chronic liver disease: lessons learned from experimental mouse models
Linda Hammerich et al.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2014)
Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis
Tamar Mchedlidze et al.
IMMUNITY (2013)
Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
Ingmar Mederacke et al.
NATURE COMMUNICATIONS (2013)
IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice
Jan Petrasek et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells
Nozomu Sakai et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Oncogenic Smad3 Signaling Induced by Chronic Inflammation Is an Early Event in Ulcerative Colitis-associated Carcinogenesis
Seiji Kawamata et al.
INFLAMMATORY BOWEL DISEASES (2011)
Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice
Yehuda Kamari et al.
JOURNAL OF HEPATOLOGY (2011)
Adipose and Liver Expression of Interleukin (IL)-1 Family Members in Morbid Obesity and Effects of Weight Loss
Alexander R. Moschen et al.
MOLECULAR MEDICINE (2011)
Interleukin 37 expression protects mice from colitis
Eoin N. McNamee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
In Vivo Expression of Interleukin-37 Reduces Local and Systemic Inflammation in Concanavalin A-Induced Hepatitis
Ana-Maria Bulau et al.
THESCIENTIFICWORLDJOURNAL (2011)
Interleukin-33 overexpression is associated with liver fibrosis in mice and humans
Pierrick Marvie et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
IL-37 is a fundamental inhibitor of innate immunity
Marcel F. Nold et al.
NATURE IMMUNOLOGY (2010)
Liver Myofibroblasts Regulate Infiltration and Positioning of Lymphocytes in Human Liver
Andrew P. Holt et al.
GASTROENTEROLOGY (2009)
Hepatic Recruitment of the Inflammatory Gr1+ Monocyte Subset Upon Liver Injury Promotes Hepatic Fibrosis
Karlin Raja Karlmark et al.
HEPATOLOGY (2009)
Pivotal role of Smad3 in a mouse model of T cell-mediated hepatitis
Michael Kremer et al.
HEPATOLOGY (2008)
TLR4 enhances TGF-β signaling and hepatic fibrosis
Ekihiro Seki et al.
NATURE MEDICINE (2007)
Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor β signaling, promoting cirrhosis and hepatocellular carcinoma
Koichi Matsuzaki et al.
HEPATOLOGY (2007)
Abnormal hepatic biochemistries in patients with inflammatory bowel disease
Flavia D. Mendes et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
John P. Iredale
JOURNAL OF CLINICAL INVESTIGATION (2007)
Proteomics-based identification of proteins interacting with Smad3: SREBP-2 forms a complex with Smad3 and inhibits its transcriptional activity
S Grimsby et al.
FEBS LETTERS (2004)
TGFβ1 in liver fibrosis:: time to change paradigms?
M Bauer et al.
FEBS LETTERS (2001)
Attenuation of CCl4-induced hepatic fibrosis by GdCl3 treatment or dietary glycine
CA Rivera et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2001)
Share Paper
